logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
Showing 1 - 6 of 6 Items
Showing 1 - 6 of 6 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in southwestern Uganda

Rasti R, Kumbakumba E, Nanjebe D, Mlotshwa P, Nassejje M,  et al.
2025-03-22 • BMC Infectious Diseases
2025-03-22 • BMC Infectious Diseases

BACKGROUND

In low-resource settings, limited laboratory capacity adds to the burden of central nervous system (CNS) infections in children and spurs overuse of ...

Journal Article
|
Research

Outcome of children with presumptive tuberculosis in Mbarara, rural Uganda

Bonnet MMB, Nansumba M, Bastard M, Orikiriza P, Kyomugasho N,  et al.
2017-08-02 • Pediatric Infectious Disease Journal
2017-08-02 • Pediatric Infectious Disease Journal
BACKGROUND
Mortality among children with presumptive tuberculosis (TB) empiric TB treatment can be high. We describe the predictors of death among children with presumptive TB, and t...
Journal Article
|
Research

Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting

Orikiriza P, Nansumba M, Nyehangane D, Bastard M, Mugisha IT,  et al.
2018-05-08 • European Journal of Clinical Microbiology and Infectious Diseases
2018-05-08 • European Journal of Clinical Microbiology and Infectious Diseases
The Xpert MTB/RIF assay is a major advance for diagnosis of tuberculosis (TB) in high-burden countries but is limited in children by their difficulty to produce sputum. We investigated T...
Protocol
|
Research Protocol

Point-of-care approaches for meningitis diagnosis in a low-resource setting (Southwestern Uganda): observational cohort study protocol of the “PI-POC” trial

Gaudenzi G, Kumbakumba E, Rasti R, Nanjebe D, Reu P,  et al.
2020-11-04 • JMIR Research Protocols
2020-11-04 • JMIR Research Protocols
BACKGROUND
A timely differential diagnostic is essential to identify the etiology of central nervous system (CNS) infections in children, in order to facilitate targeted treatment, m...
Journal Article
|
Research

Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children

Nansumba M, Kumbakumba E, Orikiriza P, Bastard M, Mwanga JP,  et al.
2018-02-01 • International Journal of Tuberculosis and Lung Disease
2018-02-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
In 2010, the World Health Organization (WHO) revised the paediatric dosages of anti-tuberculosis drugs, increasing rifampicin to 15 mg/kg, isoniazid to 10 mg/kg and pyrazi...
Journal Article
|
Research

Detection yield and tolerability of string test for diagnosis of childhood intrathoracic tuberculosis

Nansumba M, Kumbakumba E, Orikiriza P, Muller Y, Nackers F,  et al.
2016-02-01 • Pediatric Infectious Disease Journal
2016-02-01 • Pediatric Infectious Disease Journal
BACKGROUND
Difficulty to obtain sputum in children complicates diagnosis of intrathoracic tuberculosis (TB). The intragastric string test (ST) used for retrieval of enteric pathogens...